Chemoradiotherapy was identical in the postoperative-treatment group, except for the delivery of a boost of 5.40 Gy. The primary end point was overall survival. The results of this study were ...

We hope to add results when they are available. A usual treatment for cancer of the cervix is a combination of chemotherapy and radiotherapy. This is called chemoradiotherapy. Sometimes the cancer ...

During the past 20 years, the advent of neoadjuvant, primary, and adjuvant concurrent chemoradiotherapy has improved cancer care dramatically. Significant contributions have been made by ...

For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was ...

SAN FRANCISCO -- Neoadjuvant chemoradiotherapy with or without the investigational PD-1 inhibitor sintilimab significantly increased pathological complete response (pCR) rates compared with ...

Background: Esophagectomy following neoadjuvant chemoradiotherapy (nCRT) is a curative treatment for locally advanced esophageal cancer. However, pulmonary complications are the most common ...

The researchers found that overall survival at three years was 57.4 and 50.7 percent in the FLOT and preoperative-chemoradiotherapy groups, respectively, with a median follow-up of 55 months ...

Perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) demonstrates superior outcomes than preoperative chemoradiotherapy in resectable esophageal ...